Universal Ibogaine Inc.
IBO.V
TSX
Weiss Ratings | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Weak | |||
Risk Grade | D- | |||
Reward Grade | E | |||
Rating Factors | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Very Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Fair | |||
Total Return Index | Fair | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.67 | |||
Price History | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 0.00% | |||
30-Day Total Return | 25.00% | |||
60-Day Total Return | 66.67% | |||
90-Day Total Return | 150.00% | |||
Year to Date Total Return | 150.00% | |||
1-Year Total Return | -16.67% | |||
2-Year Total Return | 25.00% | |||
3-Year Total Return | -68.75% | |||
5-Year Total Return | -- | |||
52-Week High % Change | -16.67% | |||
52-Week Low % Change | 400.00% | |||
Price | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.03 | |||
52-Week Low Price | $0.01 | |||
52-Week Low Price (Date) | Jun 27, 2024 | |||
52-Week High Price (Date) | Mar 07, 2024 | |||
Valuation | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 5.35M | |||
Enterprise Value | 6.95M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -0.01 | |||
Earnings Per Share Growth | -81.41% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 4.17 | |||
Price/Book (Q) | 6.41 | |||
Enterprise Value/Revenue (TTM) | 3.97 | |||
Price | $0.03 | |||
Enterprise Value/EBITDA (TTM) | -19.42 | |||
Enterprise Value/EBIT | -11.42 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 284.45M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 855-426-4246 | |||
Address | 815 8th Avenue SW Calgary, AB T2P 3P2 | |||
Website | universalibogaine.com | |||
Country | Canada | |||
Year Founded | -- | |||
Profitability | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -34.76% | |||
Profit Margin | -66.82% | |||
Management Effectiveness | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -9.16% | |||
Return on Equity | -- | |||
Income Statement | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 1.73M | |||
Total Revenue (TTM) | 1.73M | |||
Revenue Per Share | $0.01 | |||
Gross Profit (TTM) | 489.40K | |||
EBITDA (TTM) | -353.40K | |||
EBIT (TTM) | -600.80K | |||
Net Income (TTM) | -1.15M | |||
Net Income Avl. to Common (TTM) | -1.15M | |||
Total Revenue Growth (Q YOY) | 25.08% | |||
Earnings Growth (Q YOY) | -76.87% | |||
EPS Diluted (TTM) | -0.01 | |||
EPS Diluted Growth (Q YOY) | -15.79% | |||
Balance Sheet | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 342.10K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 529.60K | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 1.13M | |||
Current Ratio (Q) | 0.648 | |||
Book Value Per Share (Q) | $0.00 | |||
Total Assets (Q) | 3.87M | |||
Total Current Liabilities (Q) | 817.20K | |||
Total Debt (Q) | 2.02M | |||
Total Liabilities (Q) | 2.74M | |||
Total Common Equity (Q) | 1.13M | |||
Cash Flow | IBO.V - TSX | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | -15.90K | |||
Cash from Financing (TTM) | 653.80K | |||
Net Change in Cash (TTM) | 86.70K | |||
Levered Free Cash Flow (TTM) | -238.40K | |||
Cash from Operations (TTM) | -551.30K | |||